Medistim ASA (LON:0OCD)

Medistim ASA Statistics

Total Valuation

Medistim ASA has a market cap or net worth of GBP 308.33 million. The enterprise value is 294.63 million.

Market Cap	308.33M
Enterprise Value	294.63M

Important Dates

The last earnings date was Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	May 9, 2025

Share Statistics

Current Share Class	18.28M
Shares Outstanding	n/a
Shares Change (YoY)	-0.21%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	2.94%
Owned by Institutions (%)	84.18%
Float	12.54M

Valuation Ratios

The trailing PE ratio is 26.28 and the forward PE ratio is 25.36.

PE Ratio	26.28
Forward PE	25.36
PS Ratio	5.98
PB Ratio	8.93
P/TBV Ratio	11.21
P/FCF Ratio	n/a
P/OCF Ratio	21.84
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	25.11
EV / Sales	5.37
EV / EBITDA	17.88
EV / EBIT	19.15
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.34, with a Debt / Equity ratio of 0.08.

Current Ratio	3.34
Quick Ratio	2.21
Debt / Equity	0.08
Debt / EBITDA	0.18
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 35.18% and return on invested capital (ROIC) is 52.43%.

Return on Equity (ROE)	35.18%
Return on Assets (ROA)	19.85%
Return on Invested Capital (ROIC)	52.43%
Return on Capital Employed (ROCE)	37.92%
Weighted Average Cost of Capital (WACC)	10.01%
Revenue Per Employee	334,912
Profits Per Employee	76,199
Employee Count	154
Asset Turnover	1.13
Inventory Turnover	0.80

Taxes

In the past 12 months, Medistim ASA has paid 3.51 million in taxes.

Income Tax	3.51M
Effective Tax Rate	23.03%

Stock Price Statistics

The stock price has increased by +11.35% in the last 52 weeks. The beta is 1.06, so Medistim ASA's price volatility has been similar to the market average.

Beta (5Y)	1.06
52-Week Price Change	+11.35%
50-Day Moving Average	226.55
200-Day Moving Average	215.39
Relative Strength Index (RSI)	45.79
Average Volume (20 Days)	2,242

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medistim ASA had revenue of GBP 51.58 million and earned 11.73 million in profits. Earnings per share was 0.64.

Revenue	51.58M
Gross Profit	42.13M
Operating Income	14.46M
Pretax Income	15.25M
Net Income	11.73M
EBITDA	15.48M
EBIT	14.46M
Earnings Per Share (EPS)	0.64

Balance Sheet

The company has 15.63 million in cash and 2.76 million in debt, with a net cash position of 12.87 million.

Cash & Cash Equivalents	15.63M
Total Debt	2.76M
Net Cash	12.87M
Net Cash Per Share	n/a
Equity (Book Value)	34.52M
Book Value Per Share	1.89
Working Capital	24.66M

Cash Flow

Operating Cash Flow	14.12M
Capital Expenditures	n/a
Depreciation & Amortization	1.08M
Net Borrowing	-685,447
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 81.68%, with operating and profit margins of 28.04% and 22.75%.

Gross Margin	81.68%
Operating Margin	28.04%
Pretax Margin	29.56%
Profit Margin	22.75%
EBITDA Margin	30.02%
EBIT Margin	28.04%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.44, which amounts to a dividend yield of 0.21%.

Dividend Per Share	0.44
Dividend Yield	0.21%
Dividend Growth (YoY)	32.83%
Years of Dividend Growth	1
Payout Ratio	68.76%
Buyback Yield	0.21%
Shareholder Yield	0.41%
Earnings Yield	3.81%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6